Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Understanding whats firmly established, whats still under investigation, and how safety is monitored is essential
TRANSCEND-T2D-1 (The Lancet, June 2026): HbA1c reductions up to 2.0% and weight loss up to 16.8% in type 2 diabetes patients at 40 weeks, with no plateau observed
Toxicology studies have shown no lethal dose (LD1) could be achieved in animal models, suggesting a wide therapeutic window
However, REGEN does not prevent future injuries, so users returning to activities that caused the original injury risk re-injury if underlying biomechanics or training errors are not addressed
US$ 27.00
US$ 22.27
US$ 29.50
US$ 22.31
US$ 24.17
US$ 21.25
US$ 23.64
US$ 21.64
